Home LiteratureArticle Details
PMID: 16428722 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?

Infection and immunity ·Vol. 74 ·No. 2 ·2006-02-00 ·Pages 803-9

Lang ML, Glatman-Freedman A

Abstract

暂无摘要

MeSH Terms
Antibodies, Bacterial/biosynthesis,immunology Antigen-Presenting Cells/immunology,metabolism Antigens, CD1/metabolism Humans Mycobacterium tuberculosis/immunology,pathogenicity T-Lymphocytes/immunology,metabolism Tuberculosis/immunology,microbiology
Chemicals
Antibodies, Bacterial Antigens, CD1
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lang Mark L
Department of Microbiology and Immunology, 632W Borwell Building, Dartmouth Medical School, One Medical Center Drive, Lebanon, NH 03756, USA. Mark.L.Lang@Dartmouth.edu
Glatman-Freedman Aharona
References (78)
78 references, click to expand
  1. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
    Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10685-90 PMID: 15243159
  2. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    J Exp Med. 2003 Apr 21;197(8):1051-7 PMID: 12695492
  3. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.
    Clin Exp Immunol. 2004 Oct;138(1):30-8 PMID: 15373902
  4. Phagosomes are competent organelles for antigen cross-presentation.
    Nature. 2003 Sep 25;425(6956):402-6 PMID: 14508490
  5. Relationship between immunity and circulating antibodies, complement and tuberculopolysaccharide in tuberculosis.
    J Infect Dis. 1957 Sep-Oct;101(2):109-18 PMID: 13475868
  6. Prospects for better tuberculosis vaccines.
    Lancet Infect Dis. 2001 Aug;1(1):21-8 PMID: 11871406
  7. Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.
    J Infect Dis. 1998 Mar;177(3):807-11 PMID: 9498471
  8. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion.
    Mol Biol Cell. 2004 Feb;15(2):751-60 PMID: 14617817
  9. Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?
    Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):686-92 PMID: 1287946
  10. Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan.
    Clin Exp Immunol. 1990 Apr;80(1):141-8 PMID: 2138940
  11. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Cell Immunol. 2000 Jan 10;199(1):37-42 PMID: 10675273
  12. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest.
    Curr Opin Microbiol. 2004 Feb;7(1):71-7 PMID: 15036144
  13. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.
    J Exp Med. 1990 Aug 1;172(2):631-40 PMID: 2373994
  14. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis.
    Vaccine. 2003 Sep 8;21(25-26):4081-93 PMID: 12922145
  15. Meningococcal polysaccharide-protein conjugate vaccines.
    Lancet Infect Dis. 2005 Jan;5(1):21-30 PMID: 15620558
  16. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
    J Exp Med. 2003 Jul 21;198(2):267-79 PMID: 12874260
  17. Recognition of bacterial glycosphingolipids by natural killer T cells.
    Nature. 2005 Mar 24;434(7032):520-5 PMID: 15791257
  18. Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T cells.
    J Immunol. 2005 Feb 15;174(4):1787-90 PMID: 15699104
  19. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
    J Immunol. 1999 Sep 1;163(5):2373-7 PMID: 10452969
  20. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.
    Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3383-8 PMID: 15722411
  21. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    J Immunol. 2004 Sep 15;173(6):3693-706 PMID: 15356115
  22. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
    Nature. 2005 Mar 24;434(7032):525-9 PMID: 15791258
  23. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.
    Tuberculosis (Edinb). 2003;83(1-3):91-7 PMID: 12758196
  24. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy.
    FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):9-16 PMID: 14556990
  25. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
    Int Immunol. 2005 Jul;17(7):899-908 PMID: 15967785
  26. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.
    J Immunol. 2003 Aug 15;171(4):1637-41 PMID: 12902459
  27. Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells.
    Immunol Lett. 1999 Jan;65(1-2):85-91 PMID: 10065632
  28. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest.
    J Cell Biol. 2001 Aug 6;154(3):631-44 PMID: 11489920
  29. CD1: antigen presentation and T cell function.
    Annu Rev Immunol. 2004;22:817-90 PMID: 15032598
  30. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
    J Immunol. 2005 May 1;174(9):5681-6 PMID: 15843569
  31. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses.
    J Immunol. 2000 May 15;164(10):5005-9 PMID: 10799852
  32. The future of meningococcal vaccines.
    Pediatr Infect Dis J. 2005 Feb;24(2):175-6 PMID: 15702048
  33. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity.
    Nat Med. 2003 May;9(5):582-8 PMID: 12669034
  34. The role of iron in infections with intracellular bacteria.
    Immunol Lett. 2003 Jan 22;85(2):193-5 PMID: 12527227
  35. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.
    Immunology. 2004 Mar;111(3):328-33 PMID: 15009434
  36. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells.
    Science. 1999 Jan 8;283(5399):225-9 PMID: 9880256
  37. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi.
    J Immunol. 2000 Nov 1;165(9):4797-801 PMID: 11046002
  38. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
    Nat Med. 2003 Aug;9(8):1039-46 PMID: 12872166
  39. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    J Exp Med. 2003 Apr 21;197(8):997-1005 PMID: 12695491
  40. Marginal-zone B cells.
    Nat Rev Immunol. 2002 May;2(5):323-35 PMID: 12033738
  41. TREATMENT of pulmonary tuberculosis with isoniazid; an interim report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.
    Br Med J. 1952 Oct 4;2(4787):735-46 PMID: 12978309
  42. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
    Arch Intern Med. 2003 May 12;163(9):1009-21 PMID: 12742798
  43. The phagosome proteome: insight into phagosome functions.
    J Cell Biol. 2001 Jan 8;152(1):165-80 PMID: 11149929
  44. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15688-93 PMID: 9861031
  45. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest.
    Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5437-42 PMID: 12702770
  46. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.
    Commun Dis Public Health. 2002 Sep;5(3):220-5 PMID: 12434692
  47. Synthesis and immunologic characterisation of Mycobacterium tuberculosis lipoarabinomannan specific oligosaccharide-protein conjugates.
    Vaccine. 1999 Jul 16;17(22):2853-61 PMID: 10438056
  48. The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
    Annu Rev Immunol. 2003;21:483-513 PMID: 12543936
  49. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo.
    J Immunol. 2005 Apr 15;174(8):4696-705 PMID: 15814694
  50. Mycobacterium and the coat of many lipids.
    J Cell Biol. 2002 Aug 5;158(3):421-6 PMID: 12147678
  51. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Nat Immunol. 2002 Sep;3(9):867-74 PMID: 12154358
  52. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.
    N Engl J Med. 2001 Apr 26;344(17):1263-9 PMID: 11320385
  53. Liposomes as a carrier for mannophosphoinositide antigens of mycobacteria.
    Indian J Biochem Biophys. 1993 Jun;30(3):160-5 PMID: 8406546
  54. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.
    Immunity. 2001 May;14(5):617-29 PMID: 11371363
  55. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    J Immunol. 2005 Sep 1;175(5):3309-17 PMID: 16116223
  56. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge.
    FEMS Immunol Med Microbiol. 2004 Jun 1;41(2):93-100 PMID: 15145452
  57. Hypothesis: how licensed vaccines confer protective immunity.
    Adv Exp Med Biol. 1996;397:169-82 PMID: 8718596
  58. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages.
    J Immunol. 1996 Nov 15;157(10):4568-75 PMID: 8906835
  59. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity.
    J Exp Med. 2003 Dec 15;198(12):1785-96 PMID: 14676294
  60. Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria.
    Med Microbiol Immunol. 1988;177(5):265-84 PMID: 2845237
  61. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules.
    Immunity. 1997 Feb;6(2):187-97 PMID: 9047240
  62. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade.
    J Exp Med. 2003 Aug 18;198(4):653-9 PMID: 12925680
  63. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
    J Immunol. 1987 May 1;138(9):3028-34 PMID: 3106496
  64. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.
    Clin Microbiol Rev. 1998 Jul;11(3):514-32 PMID: 9665981
  65. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
    Eur J Immunol. 1999 Jun;29(6):2014-25 PMID: 10382765
  66. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep. 1996 Apr 26;45(RR-4):1-18 PMID: 8602127
  67. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
    Annu Rev Immunol. 1999;17:297-329 PMID: 10358761
  68. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin.
    J Exp Med. 1996 Oct 1;184(4):1349-55 PMID: 8879207
  69. Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen.
    Clin Exp Immunol. 1992 Mar;87(3):398-403 PMID: 1371954
  70. Antibody formation to trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis.
    Infect Immun. 1972 Feb;5(2):203-12 PMID: 4117880
  71. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M.
    Infect Immun. 2000 Jan;68(1):335-41 PMID: 10603406
  72. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
    J Immunol. 2002 Oct 1;169(7):3926-33 PMID: 12244192
  73. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes.
    J Exp Med. 1993 Mar 1;177(3):679-90 PMID: 8436906
  74. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.
    Nature. 2001 Jul 12;412(6843):190-4 PMID: 11449276
  75. The significance of antigen-antibody reactions in tuberculosis.
    J Infect Dis. 1956 Jul-Aug;99(1):76-83 PMID: 13357776
  76. The interplay of an immune substance with tuberculopolysaccharide and its antibody in tuberculosis.
    J Infect Dis. 1958 Jul-Aug;103(1):52-60 PMID: 13575861
  77. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells.
    Eur J Immunol. 2000 Dec;30(12):3468-77 PMID: 11093166
  78. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan.
    J Clin Microbiol. 2004 Jul;42(7):3225-31 PMID: 15243086
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
DOI
10.1128/IAI.74.2.803-809.2006
Email
mark.l.lang@dartmouth.edu
Published
2006-02-00
Pages
803-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1360325
Subset
IM
Grants
NIAID NIH HHS · AI053192 · United States
NCRR NIH HHS · P20 RR016437 · United States
NIAID NIH HHS · R03 AI053192 · United States
NCRR NIH HHS · P20 RR16437 · United States
NIAID NIH HHS · K08 AI001691 · United States
NIAID NIH HHS · AI001691 · United States
External Links
PubMed source DOI: 10.1128/IAI.74.2.803-809.2006 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2